Kane Biotech Inc KNBIF

Primary Symbol: V.KNE

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > Technically speaking....

<< Previous

Bullboard Posts

Next >>

Comment by RoyMax123on Apr 10, 2024 2:19pm

69 Views

Post# 35981723

RE:RE:RE:RE:RE:RE:RE:RE:RE:Technically speaking....

The alt exchanges thing does not mean much, as their name implied they are just alternative exchange your broker may route your buy or sell order there if there's a better price. A lot of stocks trade even more on the alt exchanges nowadays than the old exchange.

As for Kane, if they don't pull out a rabbit of their a$$ shortly we'll get back to .10 in a blink of an eye.